Proteomic screening of glycoproteins in human plasma for frailty biomarkers

Kinza S. Shamsi, Anson Pierce, Aaron S. Ashton, Dipti G. Halade, Arlan Richardson, Sara E. Espinoza

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The application of proteomics methodology for analyzing human blood samples is of increasing importance as a noninvasive method for understanding, detecting, and monitoring disease. In particular, glycoproteomic analysis may be useful in the study of age-related diseases and syndromes, such as frailty. This study demonstrates the use of methodology for isolating plasma glycoproteins using lectins, comparing the glycoproteome by frailty status using two-dimensional polyacrylamide gel electrophoresis and identifying glycoproteins using mass spectrometry. In a pilot study, we found seven glycoproteins to differ by at least twofold in prefrail compared with nonfrail older adults, including haptoglobin, transferrin, and fibrinogen, consistent with known inflammatory and hematologic changes associated with frailty. Enzyme-linked immunosorbent assay analysis found that plasma transferrin concentration was increased in frail and prefrail older adults compared with nonfrail, confirming our proteomic findings. This work provides evidence for using a reproducible methodology for conducting clinical proteomic comparative studies of age-related diseases.

Original languageEnglish (US)
Pages (from-to)853-864
Number of pages12
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume67 A
Issue number8
DOIs
StatePublished - Aug 2012
Externally publishedYes

Fingerprint

Proteomics
Glycoproteins
Biomarkers
Transferrin
Frail Elderly
Haptoglobins
Electrophoresis, Gel, Two-Dimensional
Lectins
Fibrinogen
Mass Spectrometry
Enzyme-Linked Immunosorbent Assay

Keywords

  • Frailty
  • Proteomics

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Proteomic screening of glycoproteins in human plasma for frailty biomarkers. / Shamsi, Kinza S.; Pierce, Anson; Ashton, Aaron S.; Halade, Dipti G.; Richardson, Arlan; Espinoza, Sara E.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 67 A, No. 8, 08.2012, p. 853-864.

Research output: Contribution to journalArticle

Shamsi, Kinza S. ; Pierce, Anson ; Ashton, Aaron S. ; Halade, Dipti G. ; Richardson, Arlan ; Espinoza, Sara E. / Proteomic screening of glycoproteins in human plasma for frailty biomarkers. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2012 ; Vol. 67 A, No. 8. pp. 853-864.
@article{c2c9ff0749464e4d9e29fe0e6cf685dc,
title = "Proteomic screening of glycoproteins in human plasma for frailty biomarkers",
abstract = "The application of proteomics methodology for analyzing human blood samples is of increasing importance as a noninvasive method for understanding, detecting, and monitoring disease. In particular, glycoproteomic analysis may be useful in the study of age-related diseases and syndromes, such as frailty. This study demonstrates the use of methodology for isolating plasma glycoproteins using lectins, comparing the glycoproteome by frailty status using two-dimensional polyacrylamide gel electrophoresis and identifying glycoproteins using mass spectrometry. In a pilot study, we found seven glycoproteins to differ by at least twofold in prefrail compared with nonfrail older adults, including haptoglobin, transferrin, and fibrinogen, consistent with known inflammatory and hematologic changes associated with frailty. Enzyme-linked immunosorbent assay analysis found that plasma transferrin concentration was increased in frail and prefrail older adults compared with nonfrail, confirming our proteomic findings. This work provides evidence for using a reproducible methodology for conducting clinical proteomic comparative studies of age-related diseases.",
keywords = "Frailty, Proteomics",
author = "Shamsi, {Kinza S.} and Anson Pierce and Ashton, {Aaron S.} and Halade, {Dipti G.} and Arlan Richardson and Espinoza, {Sara E.}",
year = "2012",
month = "8",
doi = "10.1093/gerona/glr224",
language = "English (US)",
volume = "67 A",
pages = "853--864",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Proteomic screening of glycoproteins in human plasma for frailty biomarkers

AU - Shamsi, Kinza S.

AU - Pierce, Anson

AU - Ashton, Aaron S.

AU - Halade, Dipti G.

AU - Richardson, Arlan

AU - Espinoza, Sara E.

PY - 2012/8

Y1 - 2012/8

N2 - The application of proteomics methodology for analyzing human blood samples is of increasing importance as a noninvasive method for understanding, detecting, and monitoring disease. In particular, glycoproteomic analysis may be useful in the study of age-related diseases and syndromes, such as frailty. This study demonstrates the use of methodology for isolating plasma glycoproteins using lectins, comparing the glycoproteome by frailty status using two-dimensional polyacrylamide gel electrophoresis and identifying glycoproteins using mass spectrometry. In a pilot study, we found seven glycoproteins to differ by at least twofold in prefrail compared with nonfrail older adults, including haptoglobin, transferrin, and fibrinogen, consistent with known inflammatory and hematologic changes associated with frailty. Enzyme-linked immunosorbent assay analysis found that plasma transferrin concentration was increased in frail and prefrail older adults compared with nonfrail, confirming our proteomic findings. This work provides evidence for using a reproducible methodology for conducting clinical proteomic comparative studies of age-related diseases.

AB - The application of proteomics methodology for analyzing human blood samples is of increasing importance as a noninvasive method for understanding, detecting, and monitoring disease. In particular, glycoproteomic analysis may be useful in the study of age-related diseases and syndromes, such as frailty. This study demonstrates the use of methodology for isolating plasma glycoproteins using lectins, comparing the glycoproteome by frailty status using two-dimensional polyacrylamide gel electrophoresis and identifying glycoproteins using mass spectrometry. In a pilot study, we found seven glycoproteins to differ by at least twofold in prefrail compared with nonfrail older adults, including haptoglobin, transferrin, and fibrinogen, consistent with known inflammatory and hematologic changes associated with frailty. Enzyme-linked immunosorbent assay analysis found that plasma transferrin concentration was increased in frail and prefrail older adults compared with nonfrail, confirming our proteomic findings. This work provides evidence for using a reproducible methodology for conducting clinical proteomic comparative studies of age-related diseases.

KW - Frailty

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=84866387008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866387008&partnerID=8YFLogxK

U2 - 10.1093/gerona/glr224

DO - 10.1093/gerona/glr224

M3 - Article

VL - 67 A

SP - 853

EP - 864

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 8

ER -